| -abine |
(see -arabine, -citabine) |
decitabine |
| -ac |
Anti-inflammatory agents (acetic acid derivatives) |
bromfenac; dexpemedolac |
| -acetam |
See -racetam |
|
| -actide |
Synthetic corticotropins |
seractide |
| -adol, -aldol- |
Analgesics (mixed opiate receptor agonists/ antagonists) |
tazadolene; spiradolene; levonantradol |
| -adox |
Antibacterials (quinoline dioxide derivatives) |
carbadox |
| -afenone |
Antiarrhythmics (propafenone derivatives) |
alprafenone; diprafenone |
| -afil |
PDE5 inhibitors |
tadalafil |
| -aj- |
Antiarrhythmics (ajmaline derivatives) |
lorajmine |
| -aldrate |
Antacid aluminum salts |
magaldrate |
| -algron |
Alpha1 - and alpha2 - adrenoreceptor agonists |
dabuzalgron |
| -alol |
Combined alpha and beta blockers |
labetalol; medroxalol |
| -amivir |
(see -vir) |
|
| -ampa |
Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors) |
|
| subgroups: |
| -ampanel |
Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors); antagonists |
becampanel |
| -ampator |
Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors); modulators |
forampator |
| -andr- |
Androgens |
nandrolone |
| -anib |
Angiogenesis inhibitors |
semaxanib |
| -anserin |
Serotonin 5-HT2 receptor antagonists |
altanserin; tropanserin; adatanserin |
| -antel |
Anthelmintics (undefined group) |
carbantel |
| -antrone |
Antineoplastics; anthraquinone derivatives |
pixantrone |
| -apsel |
P-selectin antagonists |
torapsel |
| -arabine |
Antineoplastics (arabinofuranosyl derivatives) |
fazarabine; fludarabine |
| aril-, -aril, -aril- |
Antiviral (arildone derivatives) |
pleconaril; arildone; fosarilate |
| -arit |
Antirheumatics (lobenzarit type) |
lobenzarit; clobuzarit |
| -arol |
Anticoagulants (dicumarol type) |
dicumarol |
| -arone |
Antiarrhythmics |
amiodarone; dronedarone |
| -arot- |
Arotinoids |
etarotene; sumarotene; tazarotene |
| subgroup: |
| -arotene |
Arotinoid derivatives |
bexarotene; linarotene; tazarotene |
| arte- |
Antimalarials (artemisin derivatives) |
arteflene |
| -ase |
Enzymes |
alglucerase; dornase alfa |
| subgroups: |
| -dismase |
Enzymes; superoxide dismutase activity (exception: orgotein) |
sudismase |
| -teplase |
Enzymes; tissue-type plasminogen activators |
alteplase; duteplase; silteplase |
| -uplase |
Enzymes; urokinase-type plasminogen activators |
saruplase; nasaruplase |
| -ast |
Antiasthmatics/antiallergics (not acting primarily as antihistamines; leukotriene biosynthesis inhibitors) |
|
| subgroups: |
| -lukast |
Antiasthmatics/antiallergics; leukotriene receptor antagonists |
cinalukast; pobilukast |
| -milast |
Antiasthmatics/antiallergics; type IV phosphodiesterase inhibitors |
piclamilast |
| -trodast |
Antiasthmatics/antiallergics; thromboxane A2 receptor antagonists |
seratrodast |
| -zolast |
Antiasthmatics/antiallergics; benzoxazole derivatives |
eclazolast; ontazolast |
| -tegr- |
Antiasthmatics/antiallergics; integrin antagonists |
valategrast |
| -astine |
Antihistaminics (histamine-H1 receptor antagonists) |
ebastine |
| -(a)tadine |
Tricyclic histaminic-H1 receptor antagonists, loratadine derivatives |
desloratadine; rupatadine; somantadine |
| -atadine |
Tricyclic antiasthmatics |
olopatadine; loratadine |
| -axine |
Antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake |
|
| subgroup: |
| -(f)axine |
|
radafaxine |
| -azenil |
Benzodiazepine receptor agonists/antagonists |
bretazenil; flumazenil |
| -azepam |
Antianxiety agents (diazepam type) |
lorazepam |
| -azepide |
Cholecystokinin receptor antagonists |
devazepide |
| -azocine |
Narcotic antagonists/agonists (6,7-benzomorphan derivatives) |
quadazocine; ketazocine |
| -azoline |
Antihistamines/local vasoconstrictors (antazoline type) |
antazoline |
| -azosin |
Antihypertensives (prazosin type) |
doxazosin |
| -bactam |
Beta-lactamase inhibitors |
sulbactam |
| -bamate |
Tranquilizers/antiepileptics (propanediol and pentanediol groups) |
meprobamate; felbamate |
| -barb, -barb- |
Barbituric acid derivatives |
phenobarbital; secobarbital; eterobarb |
| -begron |
Beta 3 adrenoreceptor agonist |
talibegron |
| -bendazole |
Anthelmintics (tibendazole type) |
cambendazole |
| -berel |
Beta estrogen receptor agonist |
prinaberel |
| -bersat |
Anticonvulsants; antimigraine (benzoylamino-benzpyran derivatives) |
carabersat; tidembersat |
| bol-, -bol- |
Anabolic steroids |
bolandiol; mibolerone |
| -bufen |
Non-steroidal anti-inflammatory agents, fenbufen derivatives |
indobufen |
| -bulin |
Antineoplastics (mitotic inhibitors; tubulin binders) |
mivobulin |
| -butan |
Antiseptics (dapabutan type) |
dapabutan; lopobutan |
| -butazone |
Anti-inflammatory analgesics (phenylbutazone type) |
mofebutazone |
| -caine |
Local anesthetics |
dibucaine |
| calci-, -calci- |
Vitamin D analogues |
calcipotriene; tacalcitol |
| -camra |
Antivirals (intracellular adhesion molecules, icam-1 derivatives) |
tremacamra |
| -camsule |
Camphorsulfonic acid derivatives used as UVA sunscreens |
ecamsule |
| -casan |
Caspase (interleukin –1b) converting enzyme inhibitors |
pralnacasan |
| -caserin |
Serotonin receptor agonists, primarily 5-HT2 |
lorcaserin; vabicaserin |
| -castat |
(see -stat) |
|
| -carbef |
Antibiotics (carbacephem derivatives) |
loracarbef |
| -catib |
Cathespin inhibitors |
balicatib |
| -cavir |
(see -vir) |
|
| cef- |
Cephalosporins |
cefazolin |
| -cept |
Receptor molecules, native or modified ( a preceding infix should designate the target) |
alvircept |
| subgroups: |
| -co- |
Receptor molecules, native or modified;complement receptors |
mirococept |
| -facept |
Receptor molecules, native or modified;lymphocyte function-associated with antigen 3 (LFA) receptor |
alefacept |
| -farcept |
Receptor molecules, native or modified; interferon receptors |
pifarcept |
| -lefacept |
Receptor molecules, native or modified; lymphocyte function-associated antigen 3 |
alefacept |
| -nercept |
Receptor molecules, native or modified; tumor necrosis factor receptors |
lenercept |
| -vircept |
Receptor molecules, native or modified; antiviral receptors |
alvircept |
| -cet |
Receptors (small molecule) |
|
| subgroup: |
| -calcet |
Receptors (small molecule); calcium |
tecalcet |
| -cetrapib |
Cholesterol ester transfer protein inhibitors |
torcetrapib |
| -cic |
Hepatoprotectives (timonacic type) |
limazocic |
| -ciclib |
Cyclin dependent kinase inhibitors |
seliciclib |
| -ciclovir |
(see -vir) |
|
| -cidib |
Cyclin dependent kinase inhibitor |
alvocidib |
| -cidin |
Natural antibiotics (undefined group) |
gramicidin |
| -ciguat |
Guanaline cyclase activator |
ataciguat; atriciguat |
| -cillin |
Penicillins |
ampicillin |
| -citabine |
Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
gemcitabine; fiacitabine; zalcitabine |
| -clidine |
Muscarinic agonists (various indications) |
vedaclidine; talsaclidine |
| -clone |
Hypnotics/tranquilizers (zopiclone type) |
pagoclone |
| -cog |
Blood coagulation factors |
|
| subgroups: |
| -eptacog |
Blood coagulation factors; blood coagulation factor VII |
eptacog alfa (activated) |
| -nonacog |
Blood coagulation factors; blood coagulation factor IX |
nonacog alfa |
| -octocog |
Blood coagulation factors; blood coagulation factor VIII |
moroctocog alfa; octocog alfa |
| -cogin |
Blood coagulation cascade inhibitor |
tifacogin |
| -conazole |
Systemic antifungals (miconazole type) |
fluconazole; oxiconazole |
| -cort- |
Cortisone derivatives |
hydrocortisone |
| -coxib |
Cyclooxygenase-2 inhibitors |
celecoxib; parecoxib; valdecoxib |
| -cridar |
(see -dar) |
|
| -crinat |
Diuretics (ethacrynic acid derivatives) |
brocrinat |
| -crine |
Acridine derivatives |
amsacrine; quinacrine |
| -cromil |
Antiallergics (cromoglicic acid derivatives) |
nedocromil |
| -curium (also -curonium) |
Neuromuscular blocking agents (quaternary ammonium compounds) |
atracurium; alcuronium; pipecuronium |
| -cycline |
Antibiotics (tetracycline derivatives) |
minocycline |
| -dan |
Positive inotropic agents (pimobendan type) |
prinoxodan; indolidan |
| -dapsone |
Antimycobacterials (diaminodiphenylsulfone derivatives) |
acedapsone |
| -dar |
Multidrug resistance inhibitors |
|
| subgroups: |
| -cridar |
Multidrug resistance inhibitors;acridine carboxamide derivatives |
elacridar |
| -icodar |
Multidrug resistance inhibitors;pipecolic acid derivatives |
biricodar |
| -quidar |
Multidrug resistance inhibitors; quinoline derivatives |
lamiquidar; zozuquidar |
| -spodar |
Multidrug resistance inhibitors; ciclosporin D derivatives |
valspodar |
| -denoson |
Adenosine A receptor agonists |
tecadenoson; binodenoson |
| -dermin |
(see -ermin) |
|
| dil-, -dil-, -dil |
Vasodilators (undefined group) |
fostedil |
| -dipine |
Phenylpyridine vasodilators (nifedipine type) |
darodipine; felodipine |
| -dismase |
(see -ase) |
|
| -distim |
(see -stim) |
|
| -ditan |
Antimigraine (5-HT1 receptor agonists) |
alniditan |
| -dopa |
Dopamine receptor agonists |
levodopa |
| -dore |
Dopamine D2D3 receptor modulators |
aplindore fumarate |
| -dotin |
Synthetic analogs of the dolastatin series |
tasidotin HCl |
| -dralazine |
Antihypertensives (hydrazine-phthalazines) |
hydralazine; endralazine |
| -dronate |
Calcium metabolism regulators |
etidronate; tiludronate |
| -dutant |
(see -tant) |
|
| -ectedin |
Ecteinascodin derivatives |
monectedin |
| -ectin |
Antiparasitics (ivermectin type) |
doramectin; moxidectin |
| -elestat |
(see -stat) |
|
| -elvakin |
(see -kin) |
|
| -emcinal |
Erythromycin derivatives lacking antibiotic activity |
mitemcinal |
| -entan |
Endothelin receptor antagonists |
bosentan |
| -eptacog |
(see -cog) |
|
| -eptakin |
(see -kin) |
|
| -erg- |
Ergot alkaloid derivatives |
pergolide |
| -eridine |
Analgesics (meperidine type) |
anileridine |
| -ermin |
Growth factors |
|
| subgroups: |
| -bermin |
Growth factors; vascular endothelial growth factors |
telbermin |
| -dermin |
Growth factors; epidermal growth factors |
murodermin |
| -fermin |
Growth factors; fibroblast growth factors |
ersofermin |
| -nermin |
Growth factors; tumor necrosis factors |
sonermin; tasonermin |
| -plermin |
Growth factors; platelet derived growth factors |
becaplermin |
| -sermin |
Growth factors; insulin-like growth factors |
mecasermin |
| -termin |
Growth factors; transforming growth factors |
cetermin |
| sub subgroups: |
| -otermin |
Growth factors; bone morphogenetic proteins |
dibotermin alfa |
| estr-, -estr- |
Estrogens |
estrone; fenestrel |
| subgroups: |
| -estrant |
Estrogen antagonists |
fulvestrant |
| -etanide |
Diuretics (piretanide type) |
bumetanide |
| -exakin |
(see -kin) |
|
| -ezolid |
Oxazolidinone antibacterials |
eperezolid; linezolid |
| -farnib |
Farnesyl transferase inhibitor |
tipifarnib |
| -fenamate |
"fenamic acid" ester, salt derivatives |
etofenamate |
| -fenamic acid |
Anti-inflammatory agents (anthranilic acid derivatives) |
flufenamic acid |
| -fenin |
Diagnostic aids ((phenylcarbamoyl)methyl iminodiacetic acid derivatives) |
arclofenin |
| -fenine |
Analgesics (fenamic acid subgroup) |
floctafenine |
| -fentanil |
Narcotic analgesics (fentanyl derivatives) |
alfentanil; mirfentanil; brifentanil |
| -fentrine |
Phosphodiesterase inhibitor |
pumafentrine |
| -fermin |
(see -ermin) |
|
| -fetamin(e) |
Amfetamine derivatives |
levmetamfetamine |
| -fiban |
Fibrinogen receptor antagonists (glycoprotein IIb/IIIa receptor antagonists) |
lamifiban; tirofiban |
| -fibatide |
(see -tide) |
|
| -fibrate |
Antihyperlipidemics (clofibrate type) |
bezafibrate |
| -filcon |
Hydrophilic contact lens materials |
alphafilcon A; xylofilcon A; mipafilcon A |
| -fingol |
Sphingosine derivatives |
cedefingol; safingol |
| -flapon |
5-lipoxygenase-activating protein (FLAP) inhibitors |
quiflapon |
| -flurane |
General inhalation anesthetics (halogenated alkane derivatives) |
enflurane |
| -fo- |
Phosphoro-derivatives |
adefovir |
| -focon |
Hydrophobic contact lens materials |
trifocon A; pasifocon B; satafocon A |
| -formin |
Hypoglycemics (phenformin type) |
buformin |
| -fradil |
Calcium channel blockers acting as vasodilators |
mibefradil |
| -fulven |
Antineoplastic, acylfulven derivatives |
viridofulven |
| -fungin |
Antifungal antibiotics (undefined group) |
kalafungin |
| -fylline |
Theophylline derivatives |
enprofylline; bamifylline; cipamfylline |
| -gab- |
Gabamimetics |
fengabine |
| gado- |
Gadolinium derivatives (principally for diagnostic use) |
gadodiamide; gadoteridol; gadobenate |
| -gapil |
Neuronal apoptosis inhibitors; GAPDH |
omigapil |
| -ganan |
Antimicrobial, bactericidal permeability increasing polypeptide |
iseganan; pexiganan |
| -gatran |
Thrombin inhibitors (argatroban type) |
efegatran |
| -gest- |
Progestins |
megestrol |
| -giline |
MAO inhibitors, type B |
selegiline |
| -gillin |
Antibiotics (Aspergillus strains) |
mitogillin |
| gli- |
Antihyperglycemics |
gliflumide |
| -gliptin |
Antihyperglycemics; dipeptidyl aminopeptidase-IV inhibitors |
vildagliptin |
| -glitazar |
Antihyperglycemics; PPAR agonists (not thiazolidene derivatives) |
farglitizar |
| -glitazone |
Antihyperglycemics; PPST agonists (thiazolidene derivatives) |
ciglitazone; rosiglitazone |
| -glumide |
CCK antagonists, antiulcer, anxiolytic agent |
amiglumide; itriglumide |
| -golix |
GnRH receptor antagonists (nonpeptide) |
rupugolix |
| -gosivir |
(see -vir) |
|
| -gramostim |
(see -stim) |
|
| -grastim |
(see -stim) |
|
| -grel-, -grel |
Platelet aggregation inhibitors (undefined group) |
itazigrel; dimetagrel; furegrelate |
| guan- |
Antihypertensives (guanidine derivatives) |
guanoctine |
| -ibat |
Ileal bile acid transport inhibitor |
barixibat |
| -icam |
Anti-inflammatory agents (isoxicam type) |
enolicam; tenoxicam |
| -icodar |
(see -dar) |
|
| -ifen(e) |
Antiestrogens of the clomifene and tamoxifen groups |
nitromifene; raloxifene; droloxifene |
| -ilide |
Class III antiarrhythmic agents |
ibutilide; risotilide; dofetilide |
| -imepodib |
Inosine monophosphate dehydrogenase inhibitors |
merimepodib |
| -imex |
Immunostimulants |
forfenimex; roquinimex; ubenimex |
| -imibe- |
Antihyperlipidaemics, acyl CoA: cholesterol acyltransferase (ACAT) inhibitors |
eldacimibe; avasimibe; pactimibe |
| -imod |
Immunomodulators |
ivarimod; pidotimod |
| subgroup: |
| -mapimod |
Immunomodulators; mitogen-activated protein (MAP) kinase inhibitors |
dormapimod |
| -imus |
Immunosuppressives |
tacrolimus; napirimus; gusperimus; sirolimus |
| io- |
Iodine-containing contrast media |
iodamide |
| -irudin |
Anticoagulants (hirudin type) |
desirudin |
| -isant |
Histamine H3 receptor antagonists |
cipralisant |
| -isomide |
Antiarrhythmics (disopyramide derivatives) |
bidisomide |
| -ium (also -onium) |
Quaternary ammonium derivatives |
clidinium; disiquonium; polixetonium |
| -ixafor |
CXCR4 antagonists |
plerixifor |
| -kacin |
Antibiotics obtained from Streptomyces kanamyceticus (related to kanamycin) |
amikacin |
| -kalant |
Potassium channel antagonists |
almokalant; terikalant |
| -kalim |
Potassium channel agonists |
cromakalim; aprikalim |
| -kalner |
Opener of large conductance calcium-activated (maxi-k) K+ channels |
flindokalner |
| -kef- |
Enkephalin agonists (various indications) |
metkephamide; casokefamide |
| -kin |
Interleukin type substances |
|
| subgroups: |
| -decakin |
Interleukin type substances; interleukin-10 analogues and derivatives |
ilodecakin |
| -dodekin |
Interleukin type substances; interleukin-12 analogues and derivatives |
edodekin alfa |
| -elvekin |
Interleukin type substances; interleukin 11 analogues and derivatives |
oprelvekin |
| -eptakin |
Interleukin type substances; interleukin 7 analogues and derivatives |
|
| -exakin |
Interleukin type substances; interleukin 6 analogues and derivatives |
atexakin alfa |
| -leukin |
Interleukin type substances; interleukin 2 analogues and derivatives |
teceleukin; aldesleukin |
| -nakin |
Interleukin 1 analogues and derivatives |
|
| sub subgroups: |
| -onakin |
Interleukin 1 analogues and derivatives; interleukin 1-a analogues and derivatives |
pitonakin |
| -benakin |
Interleukin 1 analogues and derivatives; iinterleukin 1-b analogues and derivatives |
mobenakin |
| -nonakin |
Interleukin 1 analogues and derivatives; iinterleukin 9 analogues and derivatives |
|
| -octakin |
Interleukin 1 analogues and derivatives; iinterleukin 8 analogues and derivatives |
emoctakin |
| -penkin |
Interleukin 1 analogues and derivatives; iinterleukin 5 analogues and derivatives |
|
| -trakin |
Interleukin 1 analogues and derivatives; iinterleukin 4 analogues and derivatives |
binetrakin |
| -kinra |
Interleukin receptor antagonists |
|
| subgroup: |
| -nakinra |
Interleukin receptor antagonists; interleukin 1 (IL-1) receptor antagonists |
anakinra |
| -kiren |
Renin inhibitors |
ditekiren; terlakiren; zankiren |
| -lazad |
Lipid peroxidation inhibitors |
tirilazad |
| -leptin |
Leptin derivatives |
metreleptin |
| -leukin |
(see -kin) |
|
| -lind |
Pro-apoptotic cGMP phosphodiesterase inhibitors |
ractalind; dractalind |
| subgroup: |
| -sulind |
Pro-apoptotic cGMP phosphodiesterase inhibitors; antineoplastics, sulindac metabolites |
exisulind |
| -lipim |
Lipoprotein lipase activators |
ibrolipim |
| -locib |
Antineoplastics that inhibit the formation of 5-LO, LTB4, LTC4, and thromboxane B2 (TxB2); and Activate PPARg nuclear receptors |
etalocib |
| -lubant |
Leukotriene receptor antagonists (treatment of inflammatory skin disorders) |
ticolubant |
| -lukast |
(see -ast) |
|
| -lutamide |
Antiandrogens |
bicalutamide; flutamide |
| -lutril |
Neutral endopeptidase inhibitors possessing additional endothelin converting enzyme inhibitory activity |
daglutril |
| -mab |
Monoclonal antibodies |
imciromab; abciximab; capromab; dacliximab; detumomab; enlimomab |
| subgroups: |
| -axo- |
Monoclonal antibodies; rat-murine hybrid antibodies |
|
| -les- |
Monoclonal antibodies; infix for inflammatory/infectious lesions |
|
| -toxa- |
Monoclonal antibodies; toxin as a target |
urtoxazumab |
| -mantadine, -mantine |
Antivirals/antiparkinsonians (adamantane derivatives) |
rimantadine; dopamantine |
| -mastat |
(see -stat) |
|
| -meline |
Cholinergic agonists (arecoline derivatives used in treatment of Alzheimer's disease) |
xanomeline |
| -melteon |
Selective melatonin receptor agonist |
ramelteon |
| -mer |
Polymers |
cadexomer; carbetimer |
| -mesine |
Sigma receptor ligands |
igmesine; panamesine |
| -mestane |
Antineoplastics (aromatase inhibitors) |
plomestane |
| -metacin |
Anti-inflammatory agents (indomethacin type) |
zidometacin |
| -micin |
Antibiotics (Micromonospora strains) |
maduramicin; gentamicin |
| -monam |
Monobactam antibiotics |
gloximonam; oximonam; tigemonam |
| -morelin |
(see -relin) |
|
| -moren |
Non-peptidic growth hormone secretagogues |
ibutamoren |
| -mostim |
(see -stim) |
|
| -motine |
Antivirals (quinoline derivatives) |
famotine |
| -moxin |
Monoamine oxidase inhibitors (hydrazine derivatives) |
benmoxin; domoxin |
| -mulin |
Antibacterials, pleuromulin derivatives |
retapamulin |
| -multin |
Mucosal tolerance inductors |
ismomultin |
| -mustine |
Antineoplastics (chloroethylamine derivatives) |
carmustine |
| -mycin |
Antibiotics (Streptomyces strains) |
lincomycin |
| nab-, -nab- |
Cannabinol derivatives |
nabazenil; dronabinol |
| -nakalant |
Mixed sodium/potassium channel blockers |
vernakalant |
| -nakin |
(see -kin) |
|
| nal- |
Narcotic agonists/antagonists (normorphine type) |
nalmefene |
| -navir |
(see -vir) |
|
| -nercept |
(see -cept) |
|
| -nermin |
(see -ermin) |
|
| -nertant |
Neurotensin receptor antagonists |
reminertant |
| -nesib |
Kinesin inhibitors |
ispinesib |
| -netant |
(see -tant) |
|
| -neurin |
Neurotensin receptor antagonists; neurotropins |
abrineurin |
| -nicline |
Nicotinic acetylcholine receptor partial agonists/agonists nonsteroidal anti-inflammatory agents (tenidap |
altinicline |
| -nidap |
Nonsteroidal anti-inflammatory agents (tenidap type) |
ilonidap; tenidap |
| -nidazole |
Antiprotozoal substances (metronidazole type) |
tinidazole |
| nifur- |
5-nitrofuran derivatives |
nifuratel; nifuratrone |
| -nil |
Benzodiazepine receptor antagonists/agonists |
|
| subgroups: |
| -punil |
Mitochondrial benzodiazepine receptor (MBR) selective, partial, or inverse agonists (purine derivatives) |
emapunil |
| -quinil |
Benzodiazepine receptor agonists, also partial or inverse (quinoline derivatives) |
lirequinil |
| -nixin |
Anti-inflammatory agents (anilinonicotinic acid derivatives) |
clonixin |
| -nonacog |
(see -cog) |
|
| -nonakin |
(see -kin) |
|
| -octacog |
(see -cog) |
|
| -octakin |
(see -kin) |
|
| -olol |
Beta-blockers (propranolol type) |
timolol; atenolol |
| -olone |
Steroids (not prednisolone derivatives) |
minaxolone |
| -onide |
Topical steroids (acetal derivatives) |
amcinonide |
| -opilone |
Epothilone |
filopilone |
| -orex |
Anorexiants |
fludorex |
| -orphan |
Narcotic antagonists/agonists dextro-(morphinan derivatives) |
methorphan; dextrorphan |
| -osuran |
Urotensin receptor antagonists |
palosuran |
| -otilate |
Hepatoprotectants, di-isopropyl-1,3-dithiol- malonate derivatives |
mivotilate |
| -oxacin |
Antibacterials (quinolone derivatives) |
difloxacin; ciprofloxacin |
| -oxan |
Alpha-adrenoceptor antagonists (benzodioxane derivatives) |
imiloxan |
| -oxanide |
Antiparasitics (salicylanilide derivatives) |
bromoxanide |
| -oxef |
Antibiotics (oxacefalosporanic acid derivatives) |
flomoxef |
| -oxetine |
Antidepressants (fluoxetine type) |
dapoxetine; seproxetine |
| -pafant |
Platelet-activating factor antagonists |
apafant; dacopafant; tulopafant; lexipafant |
| -pamide |
Diuretics (sulfamoylbenzoic acid derivatives) |
alipamide |
| -pamil |
Coronary vasodilators (verapamil type) |
tiapamil |
| -pamine |
Dopaminergics (butopamine type) |
fosopamine; ibopamine |
| -panel |
AMPA receptor antagonists |
fanapanel; irumpanel; talampanel |
| -parcil |
Antithrombotics |
beciparcil; iliparcil |
| -parcin |
Glycopeptide antibiotics |
avoparcin |
| -parin |
Heparin derivatives and low molecular weight (or depolymerized) heparins |
heparin; tinzaparin; dalteparin |
| -parinux |
Antithrombotyic indirect selective synthetic factor Xa inhibitors |
fondaparinux |
| -paroid |
Antithrombotics (heparinoid type) |
danaparoid; sulparoid |
| peg- |
PEGylated compounds |
pegcaristim; pegnartograstim; pegvisomant |
| -penem |
Antibacterial antibiotics (carbapenem derivatives) |
imipenem |
| -penkin |
(see -kin) |
|
| perflu- |
Blood substitutes and/or diagnostics (perfluorochemicals) |
perflubron; perflunafene |
| -peridol |
Antipsychotics (haloperidol type) |
haloperidol |
| -peridone |
Antipsychotics (risperidone type) |
risperidone; iloperidone; ocaperidone |
| -perone |
Antianxiety agents/neuroleptics (4'-fluoro-4-piperidinobutyrophenone derivatives) |
duoperone |
| -pezil |
Acetylcholinesterase inhibitors used in the treatment of Alzheimer’s disease |
icopezil; donepezil |
| -pidem |
Hypnotics/sedatives (zolpidem type) |
zolpidem; alpidem |
| -pirdine |
Cognition enhancers |
linopirdine; besipirdine; sibopirdine |
| -pirox |
Antimycotics (pyridone derivatives) |
ciclopirox |
| -pitant |
(see -tant) |
|
| -plact |
Platelet factor 4 analogs and derivatives |
iroplact |
| -pladib |
Phospholipase A2 inhibitors |
ecopladib |
| -planin |
Antibacterials (Actinoplanes strains) |
mideplanin; ramoplanin; teicoplanin |
| -platin |
Antineoplastics (platinum derivatives) |
cisplatin |
| -plasninin |
Inhibitors of plasminogen activator inhibitors – type 1 |
tiplasninin |
| -plermin |
(see -ermin) |
|
| -plestim |
(see -stim) |
|
| -plon |
Non-benzodiazepine anxiolytics, sedatives, hypnotics |
ocinaplon; zaleplon |
| -poetin |
Erythropoietins |
epoetin alfa; epoetin beta |
| -porfin |
Benzoporphyrin derivatives |
verteporfin; temoporfin |
| -pramine |
Antidepressants (imipramine type) |
lofepramine |
| -prazan |
Acid pump inhibitors, not dependent on acid activation |
omidaprazan |
| -prazole |
Antiulcer agents (benzimidazole derivatives) |
omeprazole; disuprazole |
| subgroup: |
| -maprazole |
Antiulcer agents (benzimidazole derivatives); acid pump inhibitors |
pumaprazole |
| pred-, -pred-, -pred |
Prednisone and prednisolone derivatives |
prednicarbate; cloprednol; oxisopred |
| -pressin |
Vasoconstrictors (vasopressin derivatives) |
desmopressin |
| -pride |
Sulpiride derivatives |
remoxipride; zacopride |
| -pril |
Antihypertensives (ACE inhibitors) |
enalapril; temocapril; spirapril |
| -prilat |
Antihypertensives (ACE inhibitors) (diacid analogs of the -pril entity) |
enalaprilat; spiraprilat |
| -prinim |
Nootropic agents, purine derivatives |
leteprinim |
| -prim |
Antibacterials (trimethoprim type) |
ormetoprim |
| -prisnil |
Selective progesterone receptor modulators (SPRM) |
asoprisnil |
| -pristin |
Antibacterials, pristinamycin derivatives |
quinupristin; efepristin |
| -pristone |
Progesterone receptor antagonists |
mifepristone |
| -profen |
Anti-inflammatory/analgesic agents (ibuprofen type) |
flurbiprofen |
| -prost-, -prost |
Prostaglandin derivatives |
rioprostil; dinoprost |
| -protafib |
Protein tyrosine phosphatase 1B inhibitors |
ertiprotafib |
| -pultide |
(see -tide) |
|
| -proget |
Nonsteroidal ligand for the progesterone receptor |
tanaproget |
| -queside |
Cholesterol sequestrants (glycosides) |
pamaqueside |
| -racetam |
Nootropes (piracetam type) |
piracetam |
| -racil |
Uracil type antineoplastics |
eniluracil; gemeracil; oteracil |
| -relin |
Prehormones or hormone-release stimulating peptides subgroups: |
nafarelin |
| subgroups: |
| -morelin |
Growth hormone-release stimulating peptides |
dumorelin |
| -tirelin |
Thyrotropin releasing hormone analogues |
protirelin |
| -relix |
Hormone-release inhibiting peptides aldosterone antagonists (spironolactone type) |
detirelix |
| -renone |
Aldosterone antagonists (spironolactone type) |
canrenone |
| -restat |
(see -stat) |
|
| -retin-, -retin |
Retinol derivatives |
etretinate; pelretin |
| -rev |
Therapeutic virus |
|
| subgroup: |
| -tucirev |
Therapeutic virus; tumoricidal |
lontucirev |
| -ribine |
Ribofuranil derivatives (pyrazofurin type) |
loxoribine |
| rifa- |
Antibiotics (rifamycin derivatives) |
rifapentine; rifampin |
| -rinone |
Cardiotonics (amrinone type) |
milrinone |
| -rozole |
Aromatase inhibitors (imidazole/triazole derivatives) |
letrozole; fadrozole; vorozole |
| -rsen |
Antisense oligonucleotides |
alicaforsen |
| -rubicin |
Antineoplastic antibiotics (daunorubicin type) |
esorubicin; idarubicin |
| sal-, -sal-, -sal |
Anti-inflammatory agents (salicylic acid derivatives) |
mesalamine; diflunisal; balsalazide |
| -sartan |
Angiotensin II receptor antagonists |
losartan; eprosartan |
| -semide |
Diuretics (furosemide type) |
azosemide |
| -sermin |
(see -ermin) |
|
| -serod |
Serotonin receptor antagonists and partial agonists |
piboserod |
| -serpine |
Rauwolfia alkaloid derivatives |
reserpine |
| -setron |
Serotonin 5-HT3 antagonists |
ondansetron; granisetron; lurosetron |
| -siban |
Oxytocin antagonists |
barusiban |
| -sidomine |
Antianginals (sydnone derivatives) |
pirsidomine; molsidomine; linsidomine |
| som- |
Growth hormone derivatives |
somatrem; somatropin |
| subgroups: |
| som- -bove |
Growth hormone derivatives; bovine somatotropin derivatives |
sometribove |
| som- -por |
Growth hormone derivatives; porcine somatotropin derivatives |
sometripor; somagrepor |
| -sonan |
5-HT1B receptor antagonists |
elzasonan |
| -spirone |
Anxiolytics (buspirone type) |
zalospirone; tiospirone |
| -spodar |
(see -dar) |
|
| -sporin |
Immunosuppressants (cyclosporine type) |
geclesporin; oxeclosporin |
| -stat-, -stat |
Enzyme inhibitors |
|
| subgroups: |
| -castat |
Enzyme inhibitors; dopamine beta-hydrolase (DBH) inhibitors |
nepicastat |
| -elestat |
Enzyme inhibitors; elastase inhibitors |
sivelestat |
| -inostat |
Enzyme inhibitors; inhibitors of histone deacetylase |
dacinostat |
| -mastat |
Enzyme inhibitors; antineoplastics (matrix metalloproteinase inhibitors) |
batimastat |
| -(a)mostat |
Enzyme inhibitors; proteolytic enzyme inhibitors |
nafamostat |
| -restat-, -restat |
Aldose-reductase inhibitors |
ponalrestat; tolrestat |
| -vastatin |
Antihyperlipidemics (HMG-CoA inhibitors) |
atorvastatin; lovastatin; pravastatin |
| -urestat |
Urease inhibitor |
benurestat |
| -stat- |
Renal dehydropeptidase inhibitor |
cilastatin |
| -stat- |
Pepsin inhibitor |
pepstatin |
| -statin |
Renal dehydropeptidase inhibitor pepsin inhibitor |
cilastatin; pepstatin |
| -ster- |
Steroids (androgens, anabolics) |
testosterone |
| -steride |
Testosterone reductase inhibitors |
epristeride; fenasteride |
| -stigmine |
Cholinesterase inhibitors (physostigmine type) |
quilostigmine; teserstigmine |
| -stim |
Colony-stimulating factors |
|
| subgroups: |
| -distim |
Colony-stimulating factors; conjugates of two different types of colony-stimulating factors |
milodistim |
| -gramostim |
Colony-stimulating factors; granulocyte macrophage colony- stimulating factors (GM-CSF) |
molgramostim; regramostim; sargramostim; ecogramostim |
| -grastim |
Colony-stimulating factors; granulocyte colony-stimulating factors (G-CSF) |
filgrastim; lenograstim |
| -mostim |
Colony-stimulating factors; macrophage colony-stimulating factors (M-CSF) |
mirimostim |
| -plestim |
Colony-stimulating factors; interleukin 3 derivatives; pleiotropic colony-stimulating factors |
daniplestim |
| -stinel |
NMDA receptor antagonists (glycine recognition site) |
licostinel |
| -sulam |
Antineoplastics, apoptosis inducing sulfonamide |
indisulam |
| sulfa- |
Antimicrobials (sulfonamides derivatives) |
sulfasalazine |
| -sulfan |
Antineoplastics, alkylating agents (methanesulfonate derivatives) |
busulfan |
| -sulind |
(see -lind) |
|
| -tant |
Tachykinin (neurokinin) receptor antagonists |
|
| subgroups: |
| -dutant |
Tachykinin (neurokinin) receptor antagonists; NK2 receptor antagonists |
saredutant |
| -netant |
Tachykinin (neurokinin) receptor antagonists; NK3 receptor antagonists |
osanetant |
| -pitant |
Tachykinin (neurokinin) receptor antagonists; NK1 receptor antagonists |
dapitant; zinapitant; lanepitant |
| -tapide |
Microsomal triglyceride transfer protein (MTP) inhibitors |
implitapide |
| -taxel |
Antineoplastics, taxane derivatives |
paclitaxel |
| -tecan |
Antineoplastics (camptothecine derivatives) |
topotecan; irinotecan |
| -tecarin |
Antineoplastics (rebeccamycin derivatives) |
becatecarin |
| -tepa |
Antineoplastics (thiotepa derivatives) |
azetepa |
| -teplase |
(see -ase) |
|
| -termin |
(see -ermin) |
|
| -terol |
Bronchodilators (phenethylamine derivatives) |
albuterol |
| -tesind |
Thymidilate synthetase inhibitors (benzindole derivatives) |
metesind |
| -texafin |
Texaphryn derivatives |
motexafin |
| -thiazide |
Diuretics (thiazide derivatives) |
chlorothiazide |
| -tiapine |
Antipsychotics (dibenzothiazepine derivatives) |
quitiapine |
| -tiazem |
Calcium channel blockers (diltiazem type) |
diltiazem; clentiazem; iprotiazem |
| -tibant |
Antiasthmatics (bradykinin antagonists) |
icatibant |
| -tide |
Peptides and glycopeptides |
octreotide |
| subgroups: |
| -fibatide |
Peptides and glycopeptides; platelet aggregation inhibitors (glycoprotein IIb/IIIa receptor antagonists) |
eptifibatide |
| -pultide |
Peptides and glycopeptides; peptides used as pulmonary surfactants |
sinapultide |
| -tidine |
H2-receptor antagonists (cimetidine type) |
lupitidine; ranitidine; donetidine |
| -tinib |
Tyrosine kinase inhibitors |
canertinib; imatinib; mubritinib |
| -tirelin |
(see -relin) |
|
| -tirome |
Antihyperlidaemic, thyromimetic derivatives |
anitirome; axitirome |
| -tocin |
Oxytocin derivatives |
oxytocin |
| -toclax |
Antineoplastic, BLC-2 inhibitor |
obatoclax |
| -toin |
Antiepileptics (hydantoin derivatives) |
albutoin |
| -toran |
TLR4 receptor antagonists |
eritoran |
| -tox(a)- |
Toxins |
urtoxazumab |
| -traposin |
AP2 inhibitors |
seltraposin |
| -trexate |
Antimetabolites (folic acid derivatives) |
methotrexate |
| -trexed |
Antineoplastic thymidylate synthetase inhibitors |
pemetrexed; ralitrexed; nolatrexed |
| -tricin |
Antibiotics (polyene derivatives) |
mepartricin |
| -tril, -trilat |
Endopeptidase inhibitors |
candoxatril; candoxatrilat |
| -triptan |
Antimigraine agents (5-HT1 receptor agonists) |
naratriptan; oxitriptan; sumatriptan |
| -triptyline |
Antidepressants (dibenzo[a,d]cycloheptane derivatives) |
amitriptyline |
| -troban |
Antithrombotics (thromboxane A2 receptor antagonists) |
daltroban; sulotroban |
| -trodast |
(see -ast) |
|
| -troline |
Antipsychotics (dopamine D2 antagonists) |
carvotroline; gevotroline |
| -trombopag |
Thrombopoetin agonists |
eltrombopag |
| trop-, -trop- |
Atropine derivatives |
benztropine |
| -uclin |
Mucosal tolerance inhibitors |
|
| -uplase |
(see -ase) |
|
| -uracil |
Uracil derivatives used as thyroid antagonists and as antineoplastics |
fluorouracil |
| -uridine |
Antivirals; antineoplastics (uridine derivatives) |
idoxuridine |
| -vaptan |
Vasopressin receptor antagonists |
conivaptan; relcovaptan |
| -vastatin |
(see -stat) |
|
| -verine |
Spasmolytic agents (papaverine type) |
mebeverine |
| vin-, -vin- |
Vinca alkaloids |
vinepidine; apovincamine |
| vir-, -vir-, -vir |
Antiviral substances (undefined group) |
ganciclovir; enviradine; viroxime; alvircept; delavirdine |
| subgroups: |
| -amivir |
Antiviral substances; neuraminidase inhibitors |
zanamivir |
| -cavir |
Antiviral substances; carbocyclic nucleosides |
lobucavir |
| -cyclovir |
Antiviral substances; (acyclovir type) |
acyclovir |
| -ciclovir |
Antiviral substances; (acyclovir type) |
desciclovir; famciclovir; penciclovir |
| -gosivir |
Antiviral substances; glucosidase inhibitor |
celgosivir |
| -navir |
Antiviral substances; HIV protease inhibitors (saquinavir type) |
droxinavir; indinavir; ritonavir |
| -virdine |
Antiviral substances; (non-nucleoside reverse transcriptase inhibitors; pyridine derivatives) |
atevirdine; delevirdine |
| -virenz |
Antivirals (non-nucleoside reverse transcriptase inhibitors; benzoxazinone derivatives) |
efavirenz |
| -virsen |
Antivirals (antisense) |
afovirsen; fomivirsen; trecovirsen |
| -vircept |
(see -cept) |
|
| -virdine |
(see -vir) |
|
| -virenz |
(see -vir) |
|
| -virimat |
Antiviral, disrupts viral maturation |
bevirimat |
| -viroc |
CCR5 antagonists |
maraviroc |
| subgroup: |
| -criviroc |
CCR5 antagonists, immunomodulators |
ancriviroc |
| -vudine |
Antineoplastics; antivirals (zidovudine group) (exception: edoxudine) |
stavudine; lamivudine; alovudine |
| -xaban |
Anticoagulant (Factor Xa inhibitor) |
tamixaban |
| -xanox |
Antiallergic respiratory tract drugs (xanoxic acid derivatives) |
tixanox |
| -(x)antrone |
Antineoplastics, mitoxantrone derivatives aza-anthracenedione class of antitumor agents |
pixantrone |
| -zolamide |
Carbonic anhydrase inhibitors |
brinzolamide; dorzolamide; sezolamide |
| -zolast |
(see -ast) |
|
| -zomib |
Proteozome inhibitors |
bortezomib |
| -zotan |
5-HT1A receptor agonists/antagonists acting primarily as neuroprotectors |
robalzotan; sarizotan; ibalzotan; lecozotan |
